
|Videos|May 25, 2023
Efficacy of Immunotherapies for dMMR or MMRp Advanced/Recurrent Endometrial Cancer
The panel discusses their opinions on the use of immunotherapy in different populations of women with advanced/recurrent endometrial cancer.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
3
Developers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer
4
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
5
























































